Insights into pegRNA design from editing of the cardiomyopathy-associated phospholamban R14del mutation
Publication date
2025-09
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
Prime editing (PE) represents a transformative genome-editing technology and enables precise insertions, deletions, and base substitutions without introducing double-strand breaks, thereby reducing undesired indels and off-target effects. Despite advancements in enhanced prime editors and optimized prime editing guide RNAs (pegRNAs), designing effective pegRNAs remains a major challenge. The phospholamban (PLN) R14del mutation is associated with cardiomyopathies, making it a crucial target for precise gene-editing strategies. In this study, we explored pegRNA features that contribute to high editing efficiency using the FluoPEER.PLN R14del reporter cell line. Through systematic screening, we identified three pegRNAs with significantly enhanced editing efficiency. Our findings underscore the importance of pegRNA secondary structure and stability in optimizing prime editing, providing valuable insights into precise gene correction strategies.
Keywords
PLN R14del mutation, Phospholamban, gene therapy, pegRNA optimization, prime editing, Biophysics, Structural Biology, Biochemistry, Molecular Biology, Genetics, Cell Biology
Citation
Yao, B, Yang, Q, Snijders Blok, C J B, Daniels, M A, Doevendans, P A, Schiffelers, R, Sluijter, J P G & Lei, Z 2025, 'Insights into pegRNA design from editing of the cardiomyopathy-associated phospholamban R14del mutation', FEBS letters, vol. 599, no. 17, pp. 2543-2554. https://doi.org/10.1002/1873-3468.70097